How the first 9 months shape the rest of your life: the impact of gestational diabetes on the metabolic future
Kanat M, Abdul-Ghani M, DeFronzo RA
Diabetes Obes Metab. Pub. online 17 Jun 2026.
Leggi
Breaking news
Implementation of intermittently scanned continuous glucose monitoring and changes in hospitalizations and health care costs in insulin-treated type 2 diabetes
Rodríguez de Vera Gómez P, Mayoral E, Rodríguez Jiménez B, et al.
Diabetes Care. Pub. online 16 Jun 2026.
Leggi
Lower risk of type 2 diabetes mellitus with PCSK9 inhibitors compared with other lipid-lowering agents among patients with hyperlipidaemia
Lin JL, Hsu C, Lo SW, et al.
Diabetes Metab Res Rev. Pub. online 11 June 2026.
Leggi
GLP-1 receptor agonists and primary prevention of cancer therapy-related cardiac dysfunction
Javaid SS, Hanif M, Paulson S, et al.
Am J Cardiol. Pub. online 8 June 2026.
Leggi
Associations between adiposity indices and liver steatosis and stiffness assessed by two-dimensional shear wave elastography in patients with type 2 diabetes mellitus: a cross-sectional study
Mansour A, Amouei M, Esmaeili AH, et al.
BMC Endocr Disord. Pub. online 11 June 2026.
Leggi
Extended follow-up of type 1 diabetes immunotherapy trial participants suggests benign side effect profile
Jacobsen LM, Cuthbertson D, Felton J, et al.
Diabetes Care. Pub. online 12 June 2026.
Leggi
What is a clinically meaningful change in diabetes distress? findings for diabetes care and research from the SFDT1 cohort
Canha D, Riveline JP, Kazanlieva F, et al.
Diabetes Obes Metab. Pub. online 12 June 2026.
Leggi
Use of predicted risk and expected benefit to guide decision-making in cardiovascular-kidney-metabolic syndrome for the primary prevention of cardiovascular disease: a scientific statement from the American Heart Association and American College of Cardiology
Khan SS, Ndumele CE, Bhave N, et al.
J Am Coll Cardiol. Pub. online 9 Jun 2026.
Leggi